Sound Pharmaceuticals’ NIH Grant for a novel oral COVID-19 treatment increases to $4.2M

By News Short

Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that is has received a $1.1M supplement to its $3.1M National Center for Advancing Translational Sciences (NCATS) Award, bringing the total NIH funding to $4.2M. SPI is developing ebselen (SPI-1005), a new molecular entity with anti-viral and anti-inflammatory activity, and enrolling two Phase 2 clinical trials for the treatment of hospitalized COVID-19 patients.
Read More

Clinical Research Associate

By job

Sound Pharmaceuticals, Inc. (SPI) is a biopharmaceutical company based in Seattle, Washington that specializing in innovative and multidisciplinary approach to auditory drug development.  SPI is also making significant contributions to clinical trials in the areas of Meniere’s disease, cystic fibrosis, moderate and severe COVID-19.  We have an exciting opportunity for a Clinical Research Associate (CRA) to join our collaborative and proactive team.  This position does not require relocation.

SUMMARY

Under the direction of the VP of Clinical Operations and Regulatory Affairs Manager, the CRA contributes to the tactical implementation and conduct of clinical trial studies. The CRA ensures the quality of each clinical trial study through on-site and remote monitoring of protocol and regulatory compliance.  The CRA represents SPI at the investigator site level and maintains collaborative relationships with investigator sites, vendors, and the internal clinical operation and development team.    Read More